Details
Stereochemistry | ACHIRAL |
Molecular Formula | C8H4O4.2C6H5Hg |
Molecular Weight | 719.5 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
[Hg+]C1=CC=CC=C1.[Hg+]C2=CC=CC=C2.[O-]C(=O)C3=CC=CC=C3C([O-])=O
InChI
InChIKey=QFHSQCRSFKLKMT-UHFFFAOYSA-L
InChI=1S/C8H6O4.2C6H5.2Hg/c9-7(10)5-3-1-2-4-6(5)8(11)12;2*1-2-4-6-5-3-1;;/h1-4H,(H,9,10)(H,11,12);2*1-5H;;/q;;;2*+1/p-2
Phenylmercuric borate is classified as antimicrobial preservative. It is bactericidal against many Gram-positive and Gram-negative species. Fungicidal activity has been demonstrated against Candida albicans and Aspergillus niger. Phenylmercuric borate (PHB) is very rapidly incorporated into the cells of Escherichia coli. On the membrane, an important part of PHB seems to be associated with the ribosomes and particularly to the ribosomal proteins. Phenylmercuric borate solution is indicated for the treatment of tonsillitis, otitis, vulvovaginitis, furuncles, anthrax and ulcers, pyoderma, impetus, gingivitis and stomatitis. The regular hand disinfection with a liquid soap containing phenylmercuric borate enhanced urinary excretion of mercury indicating an increase in total daily absorption of the toxic metal. The additional amounts of mercury absorbed through the use of mercury contained in skin disinfectants are potentially dangerous for human.
Originator
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: CHEMBL2363135 Sources: https://www.ncbi.nlm.nih.gov/pubmed/358679 |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Primary | Merfen Approved Useindicated for the treatment of wounds, burns, ulcers, forúncles, anthrax, abscesses, pyodermitis, tinyes, vulvitis, vaginitis, vulvovaginitis. |
|||
Primary | Merfen Approved Useindicated for the treatment of tonsillitis, otitis, vulvovaginitis, furuncles, anthrax and ulcers, pyoderma, impetus, gingivitis and stomatitis. |
|||
Sources: https://www.ncbi.nlm.nih.gov/pubmed/13765256 |
Primary | Merfen Approved Useindicated for the treatment of wounds, burns, ulcers, forúncles, anthrax, abscesses, pyodermitis, tinyes, vulvitis, vaginitis, vulvovaginitis. |
Sample Use Guides
In Vivo Use Guide
Sources: http://www.ub.edu/pharmakoteka/node/24992
Apply a thin layer of 0.04% ointment on the affected skin area
Route of Administration:
Topical
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/3089906
Phenylmercuric borate inhibited 90% of all tested penicillinase (beta lactamase) producing strains of Neisseria gonorrhoeae (PPNG) and non-PPNGstrains at concentrations of 5 mg/l.
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Brand Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
84-70-8
Created by
admin on Fri Dec 15 15:15:17 GMT 2023 , Edited by admin on Fri Dec 15 15:15:17 GMT 2023
|
PRIMARY | |||
|
4816
Created by
admin on Fri Dec 15 15:15:17 GMT 2023 , Edited by admin on Fri Dec 15 15:15:17 GMT 2023
|
PRIMARY | |||
|
16682927
Created by
admin on Fri Dec 15 15:15:17 GMT 2023 , Edited by admin on Fri Dec 15 15:15:17 GMT 2023
|
PRIMARY | |||
|
DTXSID101018974
Created by
admin on Fri Dec 15 15:15:17 GMT 2023 , Edited by admin on Fri Dec 15 15:15:17 GMT 2023
|
PRIMARY | |||
|
FKL5QS2STU
Created by
admin on Fri Dec 15 15:15:17 GMT 2023 , Edited by admin on Fri Dec 15 15:15:17 GMT 2023
|
PRIMARY |
PARENT (SALT/SOLVATE)
SUBSTANCE RECORD